http://www.isis-innovation.com/licensing/healthoutcomes/index.html The latest Isis Outcomes news from Isis Innovation, technology transfer from the University of Oxford. http://www.isis-innovation.com/outcomes/news/IsisOutcomesatISPOR2013.html sis Outcomes will be represented at the ISPOR 18th Annual International Meeting to be held in New Orleans, from May 18th – 22nd 2013. http://www.isis-innovation.com/outcomes/news/TheElectonicEndometriosisHealthProfile-E-EHP-IsisOutcomes.html Isis Outcomes in partnership with ERT and PharmaQuest have developed an electronic questionnaire to better understand a condition that affects 10% of women. http://www.isis-innovation.com/outcomes/news/NewProductsfromIsisOutcomesatISPOR2012.html Isis Outcomes will be presenting new developments in and applications of its existing PRO portfolio, as well as demonstrating new PRO measures. http://www.isis-innovation.com/outcomes/news/NewUserManualforMIDAS.html The manual provides essential information to any user on the proper administration and scoring of the MIDAS as well as details on the development, testing, properties, validation, application and references. http://www.isis-innovation.com/outcomes/news/NewOHSOKSManuals.html Isis Outcomes has expanded the user support of two of its very popular Patient Reported Outcomes (PRO) measures, the Oxford Hip and Knee Scores. http://www.isis-innovation.com/outcomes/news/PDQrecommendedforqualityoflifemeasure.html In a recent publication that reviewed available Health-related quality of Life measures for Parkinson’s Disease, the PDQ successfully achieved “recommended” status and was cited as being the most thoroughly tested and applied questionnaire for the condition. http://www.isis-innovation.com/outcomes/news/IOtoAttendASRMConference.html Isis Outcomes will be represented at the American Society of Reproductive Medicine (ASRM) Conference to be held in Orlando, from October 15th to 19th 2011. http://www.isis-innovation.com/outcomes/news/TrialUsesPDQasEndpointMeasure.html A multi-centre trial aimed at assessing the benefits of surgical interventions in Parkinson's Disease has published its results using Isis Outcomes' Parkinson's Disease Questionnaire (the PDQ-39) as its primary endpoint measure. http://www.isis-innovation.com/outcomes/news/newoutcomesbook.html A new book has recently been published on the subject of Quality of Life Measurement in Neurodegenerative and Related Conditions. Isis Outcomes provides licences and support to users of some of the PROs described. http://www.isis-innovation.com/news/news/SymfoandIsisAnnounceTurnkeySolutionforPRO.html Isis Outcomes and Symfo are applying their respective areas of expertise to offer Sponsors and CROs a unique service that will help Drug Development / Study Managers to assess and choose the right PRO measure. http://www.isis-innovation.com/news/news/NewLanguageVersionsofEHP.html Sixteen new language versions have been completed by Oxford Outcomes Ltd, a research agency specialising in the translation and linguistic validation of patient reported outcome (PRO) measures. http://www.isis-innovation.com/news/news/IsisOutcomesatISPOR2011.html Isis Outcomes will be exhibiting at the ISPOR 16th Annual International Meeting to be held in Baltimore, from May 21st - 25th 2011. http://www.isis-innovation.com/news/news/OutcomesLicensingSuccess.html The Great Ormond Street Hospital for Children has become the 100th licensee this financial year of health questionnaires created in Oxford. http://www.isis-innovation.com/news/news/IsisOutcomesLaunchesNewSite.html Isis Outcomes, the Patient Reported Outcomes (PRO) activity within Isis Innovation, has launched its new website. http://www.isis-innovation.com/outcomes/news/NZMinistryofHealthAdoptsOxfordPROs.html Isis Outcomes is pleased to announce that the New Zealand Ministry of Health has recently concluded a licence to use the OHS and OKS in their pilot PROMs program.